Company Overview

iFabric Corp. is a Canada-based company operating in the textiles, health and wellness, and performance materials industries, with a focus on functional and protective fabric technologies and specialty consumer products. The company’s core activities center on the development and commercialization of proprietary textile treatments with antimicrobial and antiviral properties, as well as the manufacture and distribution of health and wellness products. iFabric primarily generates revenue through product sales, licensing of its technologies, and distribution agreements targeting institutional and consumer markets.

The company operates through two principal business lines: Intelligent Fabric Technologies (INFINITEX), which focuses on advanced fabric treatments and protective apparel, and Coconut Grove Pads, which produces and sells specialty feminine hygiene products. iFabric serves healthcare providers, government and institutional buyers, distributors, and retail consumers, primarily in North America. Its strategic positioning is based on proprietary technology, patent protection, and regulatory-compliant products designed for infection control and personal protection. iFabric was founded in the late 1980s and evolved from a consumer products business into a technology-oriented company as it expanded into performance textiles and medical-grade fabric applications.

Business Operations

iFabric conducts its operations through two main operating segments: Intelligent Fabric Technologies (INFINITEX) and Coconut Grove Pads. INFINITEX develops and commercializes textile treatments that impart antimicrobial, antiviral, and fluid-resistant properties to fabrics, and also designs and distributes protective apparel such as medical scrubs, personal protective equipment, and uniforms. Revenue in this segment is generated through direct product sales, treatment services for third-party manufacturers, and licensing arrangements.

Coconut Grove Pads focuses on the design, manufacturing, and distribution of specialty feminine hygiene products sold primarily through retailers and distributors. iFabric’s operations include product design, intellectual property management, quality control, and outsourced manufacturing, with production partners located in Asia and North America. The company does not rely on a single customer and maintains relationships with multiple distributors and institutional buyers, which management has stated reduces customer concentration risk.

Strategic Position & Investments

iFabric’s strategic direction emphasizes innovation in antimicrobial and antiviral textile technologies, expansion of its intellectual property portfolio, and penetration into regulated markets such as healthcare and institutional procurement. The company has invested consistently in research and development to enhance the efficacy and durability of its fabric treatments and to adapt them for new applications, including reusable protective apparel and consumer textiles.

Historically, iFabric has pursued growth through internal development rather than large-scale acquisitions. Its most notable strategic assets are its wholly owned subsidiaries Intelligent Fabric Technologies (INFINITEX) and Coconut Grove Pads, which together represent the company’s entire operating portfolio. iFabric has also focused on securing patents and trademarks related to its textile treatment technologies. Public disclosures indicate that while management has evaluated potential partnerships and distribution agreements, material acquisitions have been limited, and data on future transactions remains inconclusive based on available public sources.

Geographic Footprint

iFabric is headquartered in Canada, with its principal executive offices located in Montreal, Québec. The company’s primary markets are in Canada and the United States, where it sells protective apparel, treated textiles, and consumer health products through distributors, institutional channels, and retail partners. The majority of its revenue historically has been derived from North America.

Manufacturing and sourcing activities are conducted through third-party partners in Asia, supplementing North American production for certain product lines. While iFabric does not maintain extensive international subsidiaries, its technology licensing and sourcing relationships give it an operational footprint that spans North America and parts of Asia, providing access to global supply chains and cost-efficient manufacturing.

Leadership & Governance

iFabric is led by a management team with experience in consumer products, textiles, and public company operations. The company’s leadership emphasizes disciplined capital allocation, intellectual property development, and long-term value creation through niche market specialization rather than high-volume commoditized production. Governance practices are aligned with Canadian public company standards and are overseen by a board of directors.

Key executives include:

• Giancarlo Beevis – President & Chief Executive Officer
• David Parry – Chief Financial Officer
• Kerry Ribner – Director
• Howard Drate – Director

Management has articulated a strategic vision focused on leveraging proprietary fabric technologies to address infection control, safety, and wellness needs across multiple end markets, while maintaining a lean operating structure and cautious approach to expansion.